Cats vs Dogs: Why Flea Treatments Are Never Interchangeable

It is a mistake that happens in New Zealand homes more often than veterinary teams would like: a dog flea treatment is at hand, the cat needs treating, and the logic seems reasonable — same type of product, smaller animal, smaller amount should work. This reasoning has harmed and killed cats. The first rule of flea treatment for cats NZ selection is absolute: cats are not small dogs, and the metabolic differences between them have life-or-death implications for which compounds are safe to use.


The Fundamental Metabolic Difference


Cats metabolise many compounds through different pathways than dogs and humans, and are specifically deficient in some detoxification routes that dogs rely on heavily. The most clinically significant difference for antiparasitic treatments is the limited glucuronidation capacity in cats. Glucuronidation is a hepatic detoxification pathway that converts many lipophilic compounds — including some insecticides — into water-soluble forms that can be excreted. Dogs use this pathway efficiently. Cats do not.


The consequence is that compounds which dogs can process and eliminate safely can accumulate to toxic concentrations in cats because the primary elimination route is unavailable or severely limited. A cat receiving a compound that dogs tolerate well may experience progressive accumulation of that compound to levels that are harmful or fatal, through no fault of the dose that was given — simply because the cat's liver cannot process it through the same route that would keep it safe in a dog.


Permethrin: The Most Critical Example


Permethrin is a synthetic pyrethroid insecticide used in many dog flea products — both prescription and over-the-counter. It is effective against fleas and ticks in dogs and is safe at normal doses because dogs can metabolise and eliminate it through glucuronidation and other pathways. In cats, permethrin is a severe neurotoxin. It causes tremors, seizures, hyperthermia, and death if not treated promptly. The dose that a dog tolerates without difficulty can kill a cat.


Veterinary emergency clinics in New Zealand see permethrin toxicity cases in cats regularly, almost always as a result of accidental application of dog flea products or contact with recently treated dogs before the product has fully absorbed. The clinical presentation — acute onset neurological signs including tremors, hyperaesthesia, hyperthermia, and seizures — is dramatic and distressing. Treatment is intensive and not always successful. The cause is consistently the same: a well-intentioned person applied a dog product to a cat, or a cat groomed a recently-treated dog.


The Rule: Cats Get Cat Products Only


Licensed feline flea treatments have been specifically evaluated for feline safety. The compounds used — imidacloprid, fipronil, fluralaner at cat-appropriate concentrations, moxidectin at cat-appropriate doses — have been tested in cats at the licensed dose and found safe within established margins. The rule is simple and must be treated as non-negotiable: use only products that are licensed and specifically labelled for use in cats. Never apply a dog product to a cat. Never split a dog product pipette between a dog and a cat. Never apply a 'smaller amount' of a dog product on the assumption that it will be safe at reduced dose.


The surface similarity of products — same packaging style, same application method, similar appearance — does not indicate comparable safety in different species. The active ingredients matter, and some active ingredients that are safe in one species are dangerous in another.


Managing Cross-Species Risk in Multi-Pet Households


For households with both dogs and cats, management of cross-species contamination risk is ongoing. After applying a permethrin-containing dog flea product, separate the dog from any cats in the household until the product has completely dried and absorbed into the skin — this typically takes several hours. Direct contact between a cat and a dog with wet permethrin on its coat can result in permethrin toxicity in the cat through skin absorption or grooming.


The safest approach for mixed dog-cat households is to use dog products that do not contain permethrin. Advocate and the NexGard range are permethrin-free and are safe in households where both species are present when each receives only its own appropriate formulation. NexGard for dogs is not safe for cats — but the toxicity concern is not permethrin in these products.


Sourcing the Right Cat Products


For New Zealand cat owners, the practical approach is to purchase specifically licensed cat flea treatments from a reputable pet supply NZ retailer with a clear prescription for the cat — not to purchase dog products and attempt to adapt them. Reading the product label before every application, even for products you have used before, prevents the accidental use of a dog product on a cat when both might be stored together. Species-specific storage — separate areas or labelled containers for cat versus dog medications — further reduces this risk in multi-pet households.


Getting the Right Product for Your New Zealand Pet


New Zealand pet owners have access to a well-regulated market of veterinary parasite prevention products that has improved significantly in both breadth and accessibility over the past decade. The combination of prescription-only status for the most effective treatments — ensuring veterinary oversight — and the growth of authorised online retailers — ensuring competitive pricing — means that effective, consistent parasite prevention is both medically supported and economically accessible.


The practical framework for most New Zealand pet owners is straightforward: establish the appropriate product for your specific animal at the annual veterinary check-up, obtain the prescription, and source the year's supply from an authorised pet supply NZ retailer. Maintain the schedule consistently using whatever reminder system works reliably for your household, treat all animals in the household simultaneously, and include environmental management when addressing any existing infestation. This approach provides the best possible parasite protection for your pet without unnecessary complexity or cost.


When to Review Your Current Approach


Parasite management should be reviewed at any annual veterinary check-up, any time a pet changes weight significantly enough to affect its weight-range formulation, any time a new pet joins the household and requires integration into the existing programme, and any time a product appears to be failing — whether through apparent treatment failure, unexpected adverse effects, or a change in the pet's health circumstances that might create new product considerations.


The New Zealand veterinary profession is well-informed about local parasite prevalence, regional heartworm risk, and the evidence base for current product recommendations. Your local vet's advice is more specifically relevant to your area and your individual animal than any general information source — including this one. Use annual check-ups as the opportunity to validate that your current approach remains appropriate, and use authorised pet supply NZ retailers for cost-efficient routine supply between those annual reviews.